Gene expression across temporal stages of prostate development.

MP Mark M. Pomerantz
XQ Xintao Qiu
YZ Yanyun Zhu
DT David Y. Takeda
WP Wenting Pan
SB Sylvan C. Baca
AG Alexander Gusev
KK Keegan D. Korthauer
TS Tesa M. Severson
GH Gavin Ha
SV Srinivas R. Viswanathan
JS Ji-Heui Seo
HN Holly M. Nguyen
BZ Baohui Zhang
BP Bogdan Pasaniuc
CG Claudia Giambartolomei
SA Sarah A. Alaiwi
CB Connor A. Bell
EO Edward P. O’Connor
MC Matthew S. Chabot
DS David R. Stillman
RL Rosina Lis
AF Alba Font-Tello
LL Lewyn Li
PC Paloma Cejas
AB Andries M. Bergman
JS Joyce Sanders
HP Henk G. van der Poel
SG Simon A. Gayther
KL Kate Lawrenson
MF Marcos A. S. Fonseca
JR Jessica Reddy
RC Rosario I. Corona
GM Gleb Martovetsky
BE Brian Egan
TC Toni Choueiri
LE Leigh Ellis
IG Isla P. Garraway
GL Gwo-Shu Mary Lee
EC Eva Corey
HL Henry W. Long
WZ Wilbert Zwart
MF Matthew L. Freedman
request Request a Protocol
ask Ask a question
Favorite

Intensity of signal for each of the 16,047 mCRPC-enriched H3K27ac loci was ranked by adjusted P-value and fold change. The top 100 sites that had overlap with a TSS was selected. All human genes with a homologous mouse gene were converted and used in the analysis.

Raw FHCRC Mouse Prostate MPEDB cDNA Array data was downloaded from GEO (GSE19225), expression values for the genes described above were evaluated. Levels were measured relative to expression at embryonic day 14 as described34.

Box-and-whisker plots depicting the median, 25th–75th percentile interval and extremes in expression across the temporal stages of prostate development were calculated. P-value was determined by Wilcoxon signed-rank test92, comparing embryonic and post-natal samples.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A